In addition to its current liver tumor indication, HistoSonics is pursuing future indications across multiple applications including kidney, pancreas, prostate, neuro, women's health, and other significant underserved human health areas, to realize the broader potential histotripsy across multiple disease states and medical specialties. Ensure all team activities comply with HistoSonics' Quality Management System and applicable regulatory requirements including IEC 62304, FDA 21 CFR Part 820, ISO 13485, HIPAA, and SOC 2; oversee computer systems validation (CSV) activities for GxP-relevant infrastructure and validated computing environments managed by the team.